(Pyrimidin-5-yl)boronic acid → 1-Methyl-4-nitro-2-[6-(5-pyrimidinyl)pyrimidin-4-ylamino]benzene

HRID 13771

반응식

HRID 13771 반응식
Cl[C:2]1[N:7]=[CH:6][N:5]=[C:4]([NH:8][C:9]2[CH:14]=[C:13]([N+:15]([O-:17])=[O:16])[CH:12]=[CH:11][C:10]=2[CH3:18])[CH:3]=1.OB(O)[C:21]1[CH:22]=[N:23][CH:24]=[N:25][CH:26]=1>C(O)C>[CH3:18][C:10]1[CH:11]=[CH:12][C:13]([N+:15]([O-:17])=[O:16])=[CH:14][C:9]=1[NH:8][C:4]1[CH:3]=[C:2]([C:21]2[CH:22]=[N:23][CH:24]=[N:25][CH:26]=2)[N:7]=[CH:6][N:5]=1

참가 물질

4

실험 절차

3.28 g of 2-[(6-chloro)pyrimidin-4-ylamino]-1-methyl-4-nitrobenzene (Reference Example 20 (step 1)) were dissolved with heating in 130 ml of anhydrous ethanol. 1.69 g of dihydroxy(5-pyrimidinyl)borane was added, and then deaeration was performed, followed by purging with argon. 5.82 g of potassium carbonate and 2.15 g of tetrakis(triphenylphosphine)palladium (0) were added in turn, and then the mixture was heated at reflux for 7.5 hours. The reaction solution was mixed with water, followed by extraction with ethyl acetate twice, and dried over anhydrous magnesium sulfate, and then the solvent was distilled off under reduced pressure. The residue was crystallized by adding chloroform-methanol to obtain 808 mg of the objective compound as ocherous crystals.

후처리

  1. customby purging with argon
  2. addition5.82 g of potassium carbonate and 2.15 g of tetrakis(triphenylphosphine)palladium (0) were added in turn
  3. temperaturethe mixture was heated
  4. temperatureat reflux for 7.5 hours
  5. additionThe reaction solution was mixed with water
  6. extractionfollowed by extraction with ethyl acetate twice
  7. dry with materialdried over anhydrous magnesium sulfate
  8. distillationthe solvent was distilled off under reduced pressure
  9. customThe residue was crystallized
  10. additionby adding chloroform-methanol

출처 및 근거

ORD 기록
ord-a64403ea725c4d388b7aaeea14906f45
출처 데이터셋
uspto-grants-2010_06
특허 번호
US07728131B2

연결된 노트

불러오는 중…